Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D. IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.
IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.
What are the advantages of doing a chemo sensitivity test before your IPTLD treatment?
The chemrsensitivity testprovides information and guidance about the drugs that may be suited to the individual in a clinical practice. Standard oncology rely on the statistical analysis of a large treatment trials to decide which drugs to use for specific cancers. Doing the chemrsensitivity testing involves testing an individual cancer cells in the laboratory to see which drugs and which natural substances demonstrate the best response. A similar test is used to find which antibiotic is the right one to use for a particular type of bacteria causing an infection and which is antibiotic is already resistant.
Circulating tumor cells are the one that have detached from the primary tumor and flow into the blood or lymphatic circulation creating a secondary tumor. Despite their rare population, these cells exhibit metastatic attributes and are related to cancer progression. These cells can be isolated and identified for the following purposes:
1- early detection and diagnosis of new cancers
2- monitoring existing cancers
3- prognosis by providing information about the risk of recurrence of a current or old cancer.
If you have cancer this test, that helps for the molecular detection of disseminated cancer cells in the blood stream allow for the identification of a probable high risk of relapse. This test also determine the therapies most likely to be effective against your type of cancer and provides a molecular analyses for the expression of drug targets and chemo-resistance markers in the tumor cells. The test is performed by drawing blood from the patient.
The test is carried out by a few Laboratories in the world (BIOFOCUS, Germany; RGCC GROUP, Greece; LYMPHOCITE, Mexico) all providing a useful information for the selection of drugs that will have the best result for the specific cancer cell type. Want to find more if you can benefit from a treatment alternative that will get you the best possible outcome for your disease: www.iptldmd.com www.donatoperezgarcia.com